Benign metastasizing leiomyoma of the lung

Table 1 Summary of selected cases of BML

	Number of patients	Interval between uterine surgery and diagnosis of BML	Size or type of uterine myoma	Adjuvant treatment	Outcome (follow-up period)
Rivera et al.[3]	2	11 years	6 cm	GnRH agonist, tamoxifen, aromatase inhibitor	5 years
		3 years	22 × 16 × 10 cm, intramural	GnRH agonist tamoxifen, aromatase inhibitor	2 years
Egberts et al.[4].	1	10 years	-	GnRH agonist	3 years
Mogi et al. [31].	1	7 years	14 m	GnRH agonist	-
Bodner-Alder et al.[32].	1	1 year	6 × 7 cm, subserosal	GnRH agonist	3 months
Nasu et al.[10].	1	10 years	-	Aromatase inhibitor	15 months
Beck et al. [33].	1	5 years	10 × 10 cm, 8 × 8 cm subserosal	Progesterone	1 year
Wentling et al. [34].	1	6 years	5 cm	Progesterone	3 years
Goyle et al. [11].	1	5 years	-	progesterone	3 months
Moon et al. [9].	1	-	6 × 5 cm	observation	6 months
Awonuga et al.[35].	2	3 years	21 cm	Observation	-
		6 years	Six, ~30 cm (multiple)	Tamoxifen	2 years
Ki et al. (this case report)	4	None	Small	Observation	16 years
		None	10 × 10 cm	Observation	3 months
		7 years	8 × 8 cm, 5 × 7 cm	Observation	2 months
		11 years	10.5 × 8 cm, subserosal	Observation	2 years

ISSN: 1477-7819